GEBAUER, Ellen, BECHTEL-WALZ, Wibke, SCHELL, Christoph, ERBEL, Michelle, WALZ, Gerd und HERMLE, Tobias Franz, 2021. Development ofnivolumab pilimumab-associated autoimmune nephritis during steroid therapy. Freiburg: Universität.
Elsevier - Harvard (with titles)Gebauer, E., Bechtel-Walz, W., Schell, C., Erbel, M., Walz, G., Hermle, T.F., 2021. Development ofnivolumab pilimumab-associated autoimmune nephritis during steroid therapy. Universität, Freiburg. https://doi.org/10.1159/000517502
American Psychological Association 7th editionGebauer, E., Bechtel-Walz, W., Schell, C., Erbel, M., Walz, G., & Hermle, T. F. (ca. 2021). Development ofnivolumab pilimumab-associated autoimmune nephritis during steroid therapy [Cd]. Universität. https://doi.org/10.1159/000517502
Springer - Basic (author-date)Gebauer E, Bechtel-Walz W, Schell C, Erbel M, Walz G, Hermle TF (2021) Development ofnivolumab pilimumab-associated autoimmune nephritis during steroid therapy. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Gebauer, Ellen/ Bechtel-Walz, Wibke/ Schell, Christoph/ Erbel, Michelle/ Walz, Gerd/ Hermle, Tobias Franz, Development ofnivolumab pilimumab-associated autoimmune nephritis during steroid therapy, Freiburg 2021.